Jefferson Capital Q2 Revenue Beats on Strong Collections and Bluestem Deal
JCAP sits 39% above its 52-week low of $15.5.
Summary
Q2 revenue rose 16% to $177.5M, beating the $169.66M consensus, driven by strong prior deployments and the Bluestem portfolio purchase, which added $41M to U.S. collections and $11M to portfolio revenue. Adjusted EPS came in at $0.77. This follows the S-3 shelf filing in July and the Q1 report showing revenue growth but net income down 41% on higher taxes. The beat confirms the deployment strategy is working, though operating expenses rose on higher collections and court costs. Watch for the 424B prospectus supplement tied to the $588M secondary offering, which could pressure the stock.
At the time of this announcement, JCAP was trading at $21.61 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $15.50 to $23.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.